0000000000994268

AUTHOR

Aa

showing 2 related works from this author

Gluon Polarisation in the Nucleon and Longitudinal Double Spin Asymmetries from Open Charm Muoproduction

2009

The gluon polarisation in the nucleon has been determined by detecting charm production via D0 meson decay to charged K and pi in polarised muon scattering off a longitudinally polarised deuteron target. The data were taken by the COMPASS Collaboration at CERN between 2002 and 2006 and corresponds to an integrated luminosity of 2.8 fb^-1. The dominant underlying process of charm production is the photon-gluon fusion to a cc-bar pair. A leading order QCD approach gives an average gluon polarisation of (Delta g/g)_x= -0.49 +- 0.27(stat) +- 0.11(syst) at a scale mu^2 ~ 13 (GeV/c)^2 and at an average gluon momentum fraction (x) ~ 0.11. The longitudinal cross-section asymmetry for D0 production …

Nuclear and High Energy PhysicsParticle physicsMesonHigh Energy Physics::LatticeNuclear TheoryFOS: Physical sciences01 natural sciences7. Clean energyHigh Energy Physics - ExperimentNuclear physicsMomentumHigh Energy Physics - Experiment (hep-ex)Spin0103 physical sciencesCharm (quantum number)010306 general physicsNuclear ExperimentSpin-½Quantum chromodynamicsPhysicsMuon010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyInelastic muon scatteringAsymmetryGluonInelastic muon scattering; Spin; Asymmetry; Gluon polarisationGluon polarisationHigh Energy Physics::ExperimentNucleonParticle Physics - Experiment
researchProduct

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

2016

Background BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers (BCs) in men with BRCA1/2 mutations. Using the largest available dataset, we determined whether MBCs arising in BRCA1/2 mutation carriers display specific pathologic features and whether these features differ from those of BRCA1/2 female BCs (FBCs). Methods We characterised the pathologic features of 419 BRCA1/2 MBCs and, using logistic regression analysis, contrasted those with data from 9675 BRCA1/2 FBCs and with population-based data from 6351 MBCs in the Surveillance, Epidemiology, and End Results (…

Male0301 basic medicineGenotype-phenotype correlationPathologygenotype-phenotype correlationsendocrine system diseasesSettore MED/06 - Oncologia MedicaFEATURESmale breast cancerGenotype-phenotype correlationsLogistic regressionHistologic grade610 Medical sciences MedicineBreast cancer0302 clinical medicineEpidemiologyMedicine and Health SciencesPathologypolycyclic compoundsskin and connective tissue diseasesPOPULATIONRISKeducation.field_of_studyBRCA1 ProteinMenSingle NucleotideMiddle Aged3. Good healthGRADE030220 oncology & carcinogenesisMale breast canceroncologyFemaleBreast NeoplasmResearch ArticleHumanAdultmedicine.medical_specialtyCARCINOMAGenotype–phenotype correlations3122 CancersPopulation610Breast NeoplasmsBRCA1/2; genotype-phenotype correlations; histologic grade; male breast cancer; pathology; cancer research; oncologyMale breast cancer BRCA1 BRCA2Polymorphism Single NucleotideCàncer de mamaBreast Neoplasms Male03 medical and health sciencesBreast cancerSDG 3 - Good Health and Well-beingBRCA1/2Journal ArticleCarcinomamedicineHumansGenetic Predisposition to DiseasePolymorphismeducationAgedNeoplasm StagingBRCA2 Proteinbusiness.industryOdds ratiohistologic grademedicine.diseaseConfidence intervalMale breast cancer030104 developmental biologyddc:161HomesMutationcancer researchpathologyBRCA1/2; Genotype-phenotype correlations; Histologic grade; Male breast cancer; Pathology; Adult; Aged; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Breast Neoplasms Male; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Neoplasm Staging; Polymorphism Single Nucleotide; Oncology; Cancer Researchbusiness
researchProduct